Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-25

Clinical Trial Update: Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers

View source ↗

Summary

This clinical trial update reports a completed study evaluating Helicobacter pylori eradication treatment in patients with duodenal ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Helicobacter pylori eradication therapy

Snippet

Sponsor: AstraZeneca | Conditions: Duodenal Ulcer | Status: COMPLETED